Thorne HealthTech (NASDAQ: THRN) has successfully closed its initial public offering, issuing 7,000,000 shares of common stock at $10.00 each, generating total gross proceeds of $70.0 million. The shares began trading on the Nasdaq Global Select Market on September 23, 2021. BofA Securities, Cowen, and Evercore ISI served as lead book-running managers for the offering. This offering aims to enhance Thorne HealthTech's position in developing innovative health solutions.
Thorne HealthTech has announced the pricing of its initial public offering (IPO) of 7,000,000 shares at $10.00 each, aiming for gross proceeds of approximately $70 million. The shares will trade on the Nasdaq under the ticker symbol THRN, starting September 23, 2021, with the offering expected to close on September 27, 2021, pending customary conditions. The underwriters have a 30-day option for an additional 1,050,000 shares. This IPO reflects Thorne HealthTech's position as a leader in personalized health solutions.